Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!
ERBA Diagnostics, Inc. (NYSE MKT:ERB), a fully integrated in vitro diagnostics company, reported its financial results for the three months ended June 30, 2013. Sanjiv Suri, Interim Chief Executive Officer of ERBA Diagnostics, said: “I am pleased to report a continuation in the second quarter of 2013 of the turnaround we are experiencing, with a significant year-over-year improvement from net loss in the second quarter of 2012 to positive net income in the second quarter of 2013, resulting from our recent acquisition of Drew Scientific.
Hey, check out all the research scientist jobs. Post your resume today!
